Novo Nordisk A/S: Wegovy Pill Approved in the US as First Oral Glp-1 for Weight Management
A population-based study of 467 matched pairs of GLP-1 users and non-users with type 2 diabetes and liver cirrhosis found GLP-1 use associated with lower risks of death, cardiovascular events, decompensated cirrhosis, hepatic encephalopathy, and liver failure
Age-related diseases are related to structural changes in mitochondria, accompanied by the alterations of biophysical properties of the membrane including alteration in the electron transport chain complexes activities, decreased fluidity, and subsequently resulted in energy imbalance and mitochondrial failure
According to the terms of the agreement, Eli Lilly acquired the global rights to develop and commercialize OWL833 (Orforglipron)
So its being compounded with other vitamins and minerals and things that people believe should be good, but there hasnt been appropriate use and follow-up, Kenkare said